The ‘Re-Pricer’ Reckoning: Makena, Daraprim And Acthar Under Pressure

 
• By Michael McCaughan
  
increase in the cost of medicine
Makena, Daraprim and Acthar have all had a turn in the spotlight as a poster-child for outrageous drug prices. • Source: shuttershock

More from Pricing Debate

More from Market Access